Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Rachel A. Bender Ignacio"'
Autor:
Ewelina Kosmider, Jackson Wallner, Ana Gervassi, Rachel A. Bender Ignacio, Delia Pinto-Santini, German Gornalusse, Urvashi Pandey, Florian Hladik, Paul T. Edlefsen, Javier R. Lama, Ann C. Duerr, Lisa M. Frenkel
Publikováno v:
PLoS ONE, Vol 19, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/26834e94fd194993af374bc9e1aee01c
Autor:
Rachel A. Bender Ignacio, Sayan Dasgupta, Rogelio Valdez, Urvashi Pandey, Siavash Pasalar, Ricardo Alfaro, Florian Hladik, Germán Gornalusse, Javier R. Lama, Ann Duerr
Publikováno v:
iScience, Vol 25, Iss 12, Pp 105632- (2022)
Summary: Prior studies attempting to link biomarkers of immune activation with risk of acquiring HIV have relied on cross sectional samples, most without proximity to HIV acquisition. We created a nested case-control study within the Sabes study in P
Externí odkaz:
https://doaj.org/article/f6203733d5d14eb7b903e18bea87f24d
Autor:
Rachel A. Bender Ignacio, Jessica Long, Aparajita Saha, Felicia K. Nguyen, Lara Joudeh, Ethan Valinetz, Simon C. Mendelsohn, Thomas J. Scriba, Mark Hatherill, Holly Janes, Gavin Churchyard, Susan Buchbinder, Ann Duerr, Javeed A. Shah, Thomas R. Hawn
Publikováno v:
PLoS ONE, Vol 17, Iss 5 (2022)
Background Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. Methods We conducted a n
Externí odkaz:
https://doaj.org/article/40d7746c9eda499fb12fa9fe7b27ab32
Autor:
Judith M. White, Joshua T. Schiffer, Rachel A. Bender Ignacio, Shuang Xu, Denis Kainov, Aleksandr Ianevski, Tero Aittokallio, Matthew Frieman, Gene G. Olinger, Stephen J. Polyak
Publikováno v:
mBio, Vol 12, Iss 6 (2021)
ABSTRACT The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped for future pandemics. While unprecedented strides have been made developing vaccines and treatments for COVID-19, there remains a need for highly effec
Externí odkaz:
https://doaj.org/article/ab7ef23eaa6841f3946431766ef6f980
Autor:
Joshua A. Hill, Elizabeth M. Krantz, Kevin A. Hay, Sayan Dasgupta, Terry Stevens-Ayers, Rachel A. Bender Ignacio, Merav Bar, Joyce Maalouf, Sindhu Cherian, Xueyan Chen, Greg Pepper, Stanley R. Riddell, David G. Maloney, Michael J. Boeckh, Cameron J. Turtle
Publikováno v:
Blood Advances, Vol 3, Iss 22, Pp 3590-3601 (2019)
Abstract: The long-term effects of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy (CD19-CARTx) for B-cell malignancies on humoral immunity are unclear. We examined antiviral humoral immunity in 39 adults with B-cell malignanc
Externí odkaz:
https://doaj.org/article/456018df71814d50af5bee65d9178f29
Autor:
Carlee B Moser, Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz, Alex Greninger, Arzhang Cyrus Javan, Rachel A Bender Ignacio, Eric S Daar, David A Wohl, Judith S Currier, Joseph J Eron, Davey M Smith, Michael D Hughes
Publikováno v:
medRxiv
Most clinical trials evaluating COVID-19 therapeutics include assessments of antiviral activity. In recently completed outpatient trials, changes in nasal SARS-CoV-2 RNA levels from baseline were commonly assessed using analysis of covariance (ANCOVA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444c597a5db7472b83d816f388ab8361
https://europepmc.org/articles/PMC10055451/
https://europepmc.org/articles/PMC10055451/
Autor:
Rachel A, Bender Ignacio, Adrienne E, Shapiro, Robin M, Nance, Bridget M, Whitney, Joseph A C, Delaney, Laura, Bamford, Darcy, Wooten, Maile Y, Karris, William C, Mathews, Hyang Nina, Kim, Jeanne, Keruly, Greer, Burkholder, Sonia, Napravnik, Kenneth H, Mayer, Jeffrey, Jacobson, Michael, Saag, Richard D, Moore, Joseph J, Eron, Amanda L, Willig, Katerina A, Christopoulos, Jeffrey, Martin, Peter W, Hunt, Heidi M, Crane, Mari M, Kitahata, Edward R, Cachay
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
To define the incidence of clinically detected coronavirus disease 2019 (COVID-19) in people with HIV (PWH) in the United States and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.Obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f373cbbbdbd67ed113941dfe28090abf
https://doi.org/10.1097/qad.0000000000003223
https://doi.org/10.1097/qad.0000000000003223
Autor:
Christopher D. Pilcher, Javier R. Lama, Sayan Dasgupta, Serena Spudich, Siavash Pasalar, Ann Duerr, Sheila M. Keating, Rogelio Valdez, Kevin Robertson, Rachel A Bender Ignacio, August A Longino, Eduardo Ruiz, Yixin Wang, Cecilia Correa, Robert H. Paul, Peter Brandes, Alyssa Vecchio
Publikováno v:
J Acquir Immune Defic Syndr
Introduction Early systemic and central nervous system viral replication and inflammation may impact brain integrity in people with HIV (PWH), leading to chronic cognitive symptoms not fully reversed by antiretroviral therapy (ART). This study examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb4cbaa96254a3bc6705523cf1404a6
https://doi.org/10.1097/qai.0000000000002832
https://doi.org/10.1097/qai.0000000000002832
Autor:
Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, Robert Coombs, Arzhang Cyrus Javan, Rachel A Bender Ignacio, Prasanna Jagannathan, Justin Ritz, Scott Sieg, Urvi Parikh, Michael D Hughes, Judith S Currier, Davey M Smith, Kara W Chew
Publikováno v:
Open Forum Infectious Diseases. 9
Background Predictors of SARS-CoV-2 RNA levels and changes over time during early COVID-19 are not well characterized. Methods ACTIV-2 is a phase II/III randomized, placebo-controlled, platform trial to evaluate investigational agents for treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3fad721abf8a656c96ae77dd4f22560
https://doi.org/10.1093/ofid/ofac492.904
https://doi.org/10.1093/ofid/ofac492.904
Autor:
Danniel Zamora, Elizabeth M Krantz, Laurel Joncas-Schronce, Brenda Akoto, Terry L Stevens-Ayers, Rachel A Bender Ignacio, Joshua A Hill, Mariapia Degli-Esposti, Geoffrey Hill, Michael J Boeckh
Publikováno v:
Open Forum Infectious Diseases. 9
Background There is renewed interest in CMV-specific humoral immune protection due to recent murine data suggesting that strain-specific antibodies may inhibit CMV cell-to-cell spread (Science. 2019; 363:288). To characterize the nature of antibody p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a828a0d325e17787927543d22e941fa
https://doi.org/10.1093/ofid/ofac492.549
https://doi.org/10.1093/ofid/ofac492.549